The TBK1-binding domain of optineurin promotes type i interferon responses

FEBS Letters

Volumn 590, Issue 10, 2016, Pages 1498-1508

  Meena, Netra Pal ^a,e   Zhu, Guozhi ^a   Mittelstadt, Paul R ^a   Giardino Torchia, Maria Letizia ^a   Pourcelot, Marie ^b,c   Arnoult, Damien ^b,c   Ashwell, Jonathan D ^a   Munitic, Ivana ^a,d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d University of Rijeka   (Croatia)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

optineurin; TBK1; type I interferon

Indexed keywords

BETA INTERFERON; BINDING PROTEIN; OPTINEURIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; SERINE; TANK BINDING KINASE 1; UBIQUITIN; UNCLASSIFIED DRUG; EYE PROTEIN; OPTN PROTEIN, MOUSE; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; TBK1 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; PHOSPHORYLATION;

ANIMALS; BINDING SITES; EYE PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INTERFERON-BETA; MICE; PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE DELETION;

EID: 84969939705     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.12176     Document Type: Article

References (38)

1. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Heon E, Krupin T, Ritch R, Kreutzer D, et al,. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077-1079.
2. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, et al,. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223-226.
3. Zhu G, Wu CJ, Zhao Y, and, Ashwell JD, (2007) Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 17, 1438-1443.
4. Munitic I, Giardino Torchia ML, Meena NP, Zhu G, Li CC, and, Ashwell JD, (2013) Optineurin insufficiency impairs IRF3 but not NF-kappaB activation in immune cells. J Immunol 191, 6231-6240.
5. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, et al,. (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333, 228-233.
6. Tumbarello DA, Waxse BJ, Arden SD, Bright NA, Kendrick-Jones J, and, Buss F, (2012) Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol 14, 1024-1035.
7. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, Luzio JP, Kendrick-Jones J, and, Buss F, (2005) Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 169, 285-295.
8. Moreland RJ, Dresser ME, Rodgers JS, Roe BA, Conaway JW, Conaway RC, and, Hanas JS, (2000) Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res 28, 1986-1993.
9. Kachaner D, Filipe J, Laplantine E, Bauch A, Bennett KL, Superti-Furga G, Israel A, and, Weil R, (2012) Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol Cell 45, 553-566.
10. Chalasani ML, Swarup G, and, Balasubramanian D, (2009) Optineurin and its mutants: molecules associated with some forms of glaucoma. Ophthalmic Res 42, 176-184.
11. Swarup G, and, Nagabhushana A, (2010) Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling. J Biosci 35, 501-505.
12. Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, Lohr F, Wu CJ, Ashwell JD, Dotsch V, Dikic I, et al,. (2008) Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27, 3739-3745.
13. Laplantine E, Fontan E, Chiaravalli J, Lopez T, Lakisic G, Véron M, Agou F, and, Israël A, (2009) NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain. EMBO J 28, 2885-2895.
14. Schwamborn K, Weil R, Courtois G, Whiteside ST, and, Israel A, (2000) Phorbol esters and cytokines regulate the expression of the NEMO-related protein, a molecule involved in a NF-kappa B-independent pathway. J Biol Chem 275, 22780-22789.
15. Mankouri J, Fragkoudis R, Richards KH, Wetherill LF, Harris M, Kohl A, Elliott RM, and, Macdonald A, (2010) Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog 6, e1000778.
16. Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K, and, Pasparakis M, (2000) NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell 5, 981-992.
17. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, and, Lin R, (2007) The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592-600.
18. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, and, Maniatis T, (2004) IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci USA 101, 233-238.
19. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, and, Akira S, (2004) The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199, 1641-1650.
20. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, and, Maniatis T, (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491-496.
21. Helgason E, Phung QT, and, Dueber EC, (2013) Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett 587, 1230-1237.
22. Tu D, Zhu Z, Zhou AY, Yun CH, Lee KE, Toms AV, Li Y, Dunn GP, Chan E, Thai T, et al,. (2013) Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep 3, 747-758.
23. Gleason CE, Ordureau A, Gourlay R, Arthur JS, and, Cohen P, (2011) Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β. J Biol Chem 286, 35663-35674.
24. Genin P, Cuvelier F, Lambin S, Corte-Real Filipe J, Autrusseau E, Laurent C, Laplantine E, and, Weil R, (2015) Optineurin regulates the interferon response in a cell cycle-dependent manner. PLoS Pathog 11, e1004877.
25. Morton S, Hesson L, Peggie M, and, Cohen P, (2008) Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett 582, 997-1002.
26. Liu P, Jenkins NA, and, Copeland NG, (2003) A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13, 476-484.
27. Marshall-Clarke S, Downes JE, Haga IR, Bowie AG, Borrow P, Pennock JL, Grencis RK, and, Rothwell P, (2007) Polyinosinic acid is a ligand for toll-like receptor 3. J Biol Chem 282, 24759-24766.
28. Slowicka K, Vereecke L, McGuire C, Sze M, Maelfait J, Kolpe A, Saelens X, Beyaert R, and, van Loo G, (2015) Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling. Eur J Immunol 46, 971-980.
29. Sakaguchi T, Irie T, Kawabata R, Yoshida A, Maruyama H, and, Kawakami H, (2011) Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation. Neurosci Lett 505, 279-281.
30. Millecamps S, Boillee S, Chabrol E, Camu W, Cazeneuve C, Salachas F, Pradat PF, Danel-Brunaud V, Vandenberghe N, Corcia P, et al,. (2011) Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol Aging 32, 557.e11-3.
31. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, and, Randow F, (2009) The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10, 1215-1221.
32. Heo JM, Ordureau A, Paulo JA, Rinehart J, and, Harper JW, (2015) The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell 60, 7-20.
33. Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J, and, Dikic I, (2013) Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci 126, 580-592.
34. Wong YC, and, Holzbaur EL, (2014) Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci USA 111, E4439-E4448.
35. Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, and, Youle RJ, (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309-314.
36. Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, Marroquin N, Nordin F, Hubers A, Weydt P, et al,. (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18, 631-636.
37. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, et al,. (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436-1441.
38. Liu Z, Chen P, Gao H, Gu Y, Yang J, Peng H, Xu X, Wang H, Yang M, Liu X, et al,. (2014) Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell 26, 106-120.